Skip to main content
Erschienen in: Herz 6/2021

28.04.2021 | Review articles

Risk stratification for sudden cardiac death in patients with heart failure

Emerging role of imaging parameters

verfasst von: Dr. Ikram Kammoun, Emna Bennour, Lobna Laroussi, Manel Miled, Ahmed Sghaier, Karmous Rahma, Boussema Amine, Sonia Marrakchi, Salem Kachboura

Erschienen in: Herz | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Heart failure with reduced ejection fraction is a common condition that has a poor prognosis. Accurate selection of patients with ischemic heart disease and idiopathic dilated cardiomyopathy, who are at risk of sudden cardiac death (SCD), remains a challenge. In these cases, current indications for implantable cardioverter-defibrillators (ICD) rely almost entirely on left ventricular ejection fraction. However, this parameter is insufficient. Recently, noninvasive imaging has provided insight into the mechanism underlying SCD using myocardial deformation on echocardiography and magnetic resonance imaging. The aim of this review article was to underline the emerging role of these novel parameters in identifying high-risk patients.

Methods

A literature search was carried out for reports published with the following terms: “sudden cardiac death,” “heart failure,” “noninvasive imaging,” “echocardiography,” “deformation,” “magnetic resonance imaging,” and “ventricular arrhythmia.” The search was restricted to reports published in English.

Results

The findings of this analysis suggest that cardiac magnetic resonance imaging and strain assessment by echocardiography, particularly longitudinal strain, can be promising techniques for cardiovascular risk stratification in patients with heart failure.

Conclusion

In future, risk stratification of arrhythmia and patient selection for ICD placement may rely on a multiparametric approach using combinations of imaging modalities in addition to left ventricular ejection fraction.
Literatur
1.
2.
Zurück zum Zitat Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124(4):1035–1045PubMedCrossRef Tamburro P, Wilber D (1992) Sudden death in idiopathic dilated cardiomyopathy. Am Heart J 124(4):1035–1045PubMedCrossRef
3.
Zurück zum Zitat Ezekowitz JA, Armstrong PW, McAlister FA (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138(6):445–452PubMedCrossRef Ezekowitz JA, Armstrong PW, McAlister FA (2003) Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann Intern Med 138(6):445–452PubMedCrossRef
4.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237PubMedCrossRef Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237PubMedCrossRef
5.
Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883PubMedCrossRef Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883PubMedCrossRef
6.
Zurück zum Zitat Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A et al (2009) Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 30(5):576–583PubMedCrossRef Bauer A, Barthel P, Schneider R, Ulm K, Müller A, Joeinig A et al (2009) Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 30(5):576–583PubMedCrossRef
7.
Zurück zum Zitat Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG et al (2007) Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50(24):2275–2284PubMedCrossRef Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG et al (2007) Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50(24):2275–2284PubMedCrossRef
8.
Zurück zum Zitat Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17(11):1601–1687PubMed Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17(11):1601–1687PubMed
9.
Zurück zum Zitat Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al (2004) Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110(25):3760–3765PubMedCrossRef Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al (2004) Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 110(25):3760–3765PubMedCrossRef
10.
11.
Zurück zum Zitat Iacoviello M, Monitillo F (2014) Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: from imaging to electrocardiographic measures. World J Cardiol 6(7):562–576PubMedPubMedCentralCrossRef Iacoviello M, Monitillo F (2014) Non-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: from imaging to electrocardiographic measures. World J Cardiol 6(7):562–576PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M et al (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm 10(4):e11–e58PubMedCrossRef Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M et al (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm 10(4):e11–e58PubMedCrossRef
13.
Zurück zum Zitat Gorgels APM, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJJ (2003) Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24(13):1204–1209PubMedCrossRef Gorgels APM, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJJ (2003) Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24(13):1204–1209PubMedCrossRef
14.
Zurück zum Zitat Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158PubMedCrossRef Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158PubMedCrossRef
15.
Zurück zum Zitat Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator Implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230PubMedCrossRef Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, Jensen G, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, DANISH Investigators (2016) Defibrillator Implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230PubMedCrossRef
16.
Zurück zum Zitat Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK (2017) Personalizing risk stratification for sudden death in dilated cardiac the past, present, and future. Circulation 136:215–231PubMedPubMedCentralCrossRef Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK (2017) Personalizing risk stratification for sudden death in dilated cardiac the past, present, and future. Circulation 136:215–231PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Gonzalez JA, Kramer CM (2015) Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance. Curr Heart Fail Rep 12(4):276–283PubMedPubMedCentralCrossRef Gonzalez JA, Kramer CM (2015) Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance. Curr Heart Fail Rep 12(4):276–283PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Cheong BYC, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S et al (2009) Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 120(21):2069–2076PubMedCrossRef Cheong BYC, Muthupillai R, Wilson JM, Sung A, Huber S, Amin S et al (2009) Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 120(21):2069–2076PubMedCrossRef
19.
Zurück zum Zitat Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM et al (2009) Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2(3):183–190PubMedCrossRef Roes SD, Borleffs CJW, van der Geest RJ, Westenberg JJM, Marsan NA, Kaandorp TAM et al (2009) Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2(3):183–190PubMedCrossRef
20.
Zurück zum Zitat Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G et al (2005) Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45(7):1104–1108PubMedCrossRef Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G et al (2005) Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 45(7):1104–1108PubMedCrossRef
21.
Zurück zum Zitat Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B et al (2012) Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 60(5):408–420PubMedPubMedCentralCrossRef Klem I, Weinsaft JW, Bahnson TD, Hegland D, Kim HW, Hayes B et al (2012) Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol 60(5):408–420PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM et al (2006) Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114(1):32–39PubMedCrossRef Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM et al (2006) Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114(1):32–39PubMedCrossRef
23.
Zurück zum Zitat Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C et al (2011) Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 4(2):150–156PubMedCrossRef Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C et al (2011) Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging 4(2):150–156PubMedCrossRef
24.
Zurück zum Zitat Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P et al (2012) Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 5(4):448–456PubMedCrossRef Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P et al (2012) Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging. Circ Cardiovasc Imaging 5(4):448–456PubMedCrossRef
25.
Zurück zum Zitat Scott PA, Rosengarten JA, Curzen NP, Morgan JM (2013) Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15(9):1019–1027PubMedCrossRef Scott PA, Rosengarten JA, Curzen NP, Morgan JM (2013) Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail 15(9):1019–1027PubMedCrossRef
26.
Zurück zum Zitat Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985PubMedCrossRef Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985PubMedCrossRef
27.
Zurück zum Zitat Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H et al (2009) Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 53(13):1138–1145PubMedPubMedCentralCrossRef Bogun FM, Desjardins B, Good E, Gupta S, Crawford T, Oral H et al (2009) Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol 53(13):1138–1145PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Pimentel M, Zimerman LI, Rohde LE (2014) Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol 103(4):348–357PubMedPubMedCentral Pimentel M, Zimerman LI, Rohde LE (2014) Stratification of the risk of sudden death in nonischemic heart failure. Arq Bras Cardiol 103(4):348–357PubMedPubMedCentral
29.
Zurück zum Zitat Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112(18):2821–2825PubMedPubMedCentralCrossRef Nazarian S, Bluemke DA, Lardo AC, Zviman MM, Watkins SP, Dickfeld TL et al (2005) Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation 112(18):2821–2825PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51(25):2414–2421PubMedPubMedCentralCrossRef Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51(25):2414–2421PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Suzuki T, Nazarian S, Jerosch-Herold M, Chugh SS (2016) Imaging for assessment of sudden death risk: current role and future prospects. Europace 18:1491–1500PubMedPubMedCentralCrossRef Suzuki T, Nazarian S, Jerosch-Herold M, Chugh SS (2016) Imaging for assessment of sudden death risk: current role and future prospects. Europace 18:1491–1500PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ et al (2013) CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6(9):944–954PubMedPubMedCentralCrossRef Neilan TG, Coelho-Filho OR, Danik SB, Shah RV, Dodson JA, Verdini DJ et al (2013) CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging 6(9):944–954PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M (2014) Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7(2):250–258PubMedCrossRef Kuruvilla S, Adenaw N, Katwal AB, Lipinski MJ, Kramer CM, Salerno M (2014) Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis. Circ Cardiovasc Imaging 7(2):250–258PubMedCrossRef
34.
Zurück zum Zitat Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908PubMedCrossRef Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908PubMedCrossRef
35.
Zurück zum Zitat Disertori M, Rigoni M, Pace N, Casolo G, Masè M, Gonzini L, Lucci D (2016) Myocardial fibrosis assessment by LGE is a powerful predictorOf ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging 9:1046–1055PubMedCrossRef Disertori M, Rigoni M, Pace N, Casolo G, Masè M, Gonzini L, Lucci D (2016) Myocardial fibrosis assessment by LGE is a powerful predictorOf ventricular tachyarrhythmias in ischemic and nonischemic LV dysfunction: a meta-analysis. JACC Cardiovasc Imaging 9:1046–1055PubMedCrossRef
36.
Zurück zum Zitat Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White JA (2017) Sramko Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail 5:28–38PubMedCrossRef Di Marco A, Anguera I, Schmitt M, Klem I, Neilan T, White JA (2017) Sramko Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis. JACC Heart Fail 5:28–38PubMedCrossRef
37.
Zurück zum Zitat Halliday BP (2017) Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation 135:2106–2115PubMedPubMedCentralCrossRef Halliday BP (2017) Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction. Circulation 135:2106–2115PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM et al (2011) Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57(7):821–828PubMedCrossRef Iles L, Pfluger H, Lefkovits L, Butler MJ, Kistler PM, Kaye DM et al (2011) Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. J Am Coll Cardiol 57(7):821–828PubMedCrossRef
39.
Zurück zum Zitat Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H et al (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart Br Card Soc 97(9):727–732CrossRef Lehrke S, Lossnitzer D, Schöb M, Steen H, Merten C, Kemmling H et al (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart Br Card Soc 97(9):727–732CrossRef
40.
Zurück zum Zitat Li X, Chan C‑P, Hua W, Ding L, Wang J, Zhang S et al (2013) Prognostic impact of late gadolinium enhancement by cardiac magnetic resonance imaging in patients with non-ischaemic dilated cardiomyopathy. Int J Cardiol 168(5):4979–4980PubMedCrossRef Li X, Chan C‑P, Hua W, Ding L, Wang J, Zhang S et al (2013) Prognostic impact of late gadolinium enhancement by cardiac magnetic resonance imaging in patients with non-ischaemic dilated cardiomyopathy. Int J Cardiol 168(5):4979–4980PubMedCrossRef
41.
Zurück zum Zitat Müller KAL, Müller I, Kramer U, Kandolf R, Gawaz M, Bauer A et al (2013) Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study. Plos One 8(2):e57077PubMedPubMedCentralCrossRef Müller KAL, Müller I, Kramer U, Kandolf R, Gawaz M, Bauer A et al (2013) Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study. Plos One 8(2):e57077PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Nahum J, Bensaid A, Dussault C, Macron L, Clémence D, Bouhemad B et al (2010) Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 3(3):249–256PubMedCrossRef Nahum J, Bensaid A, Dussault C, Macron L, Clémence D, Bouhemad B et al (2010) Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 3(3):249–256PubMedCrossRef
43.
Zurück zum Zitat Jablonowski R (2017) Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in Ischemicand nonischemic cardiomyopathy patients using late gadolinium enhancement border zone comparison of four analysis method. Circ Cardiovasc Imaging 10:e6105PubMedPubMedCentralCrossRef Jablonowski R (2017) Cardiovascular magnetic resonance to predict appropriate implantable cardioverter defibrillator therapy in Ischemicand nonischemic cardiomyopathy patients using late gadolinium enhancement border zone comparison of four analysis method. Circ Cardiovasc Imaging 10:e6105PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart Br Card Soc 100(21):1673–1680 Kalam K, Otahal P, Marwick TH (2014) Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart Br Card Soc 100(21):1673–1680
45.
Zurück zum Zitat Antoni ML, Mollema SA, Delgado V, Atary JZ, Borleffs CJW, Boersma E et al (2010) Prognostic importance of strain and strain rate after acute myocardial infarction. Eur Heart J 31(13):1640–1647PubMedCrossRef Antoni ML, Mollema SA, Delgado V, Atary JZ, Borleffs CJW, Boersma E et al (2010) Prognostic importance of strain and strain rate after acute myocardial infarction. Eur Heart J 31(13):1640–1647PubMedCrossRef
46.
Zurück zum Zitat Bertini M, Ng ACT, Antoni ML, Nucifora G, Ewe SH, Auger D et al (2012) Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy. Circ Cardiovasc Imaging 5(3):383–391PubMedCrossRef Bertini M, Ng ACT, Antoni ML, Nucifora G, Ewe SH, Auger D et al (2012) Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy. Circ Cardiovasc Imaging 5(3):383–391PubMedCrossRef
47.
Zurück zum Zitat Iacoviello M, Puzzovivo A, Guida P, Forleo C, Monitillo F, Catanzaro R et al (2013) Independent role of left ventricular global longitudinal strain in predicting prognosis of chronic heart failure patients. Echocardiography 30(7):803–811PubMedCrossRef Iacoviello M, Puzzovivo A, Guida P, Forleo C, Monitillo F, Catanzaro R et al (2013) Independent role of left ventricular global longitudinal strain in predicting prognosis of chronic heart failure patients. Echocardiography 30(7):803–811PubMedCrossRef
48.
Zurück zum Zitat Zhang KW, French B, Khan MA, Plappert T, Fang JC, Sweitzer NK et al (2014) Strain improves risk prediction beyond ejection fraction in chronic systolic heart failure. J Am Heart Assoc 3(1):e550PubMedPubMedCentralCrossRef Zhang KW, French B, Khan MA, Plappert T, Fang JC, Sweitzer NK et al (2014) Strain improves risk prediction beyond ejection fraction in chronic systolic heart failure. J Am Heart Assoc 3(1):e550PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C et al (2010) Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr 23(10):1019–1024PubMedCrossRef Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C et al (2010) Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr 23(10):1019–1024PubMedCrossRef
50.
Zurück zum Zitat Motoki H, Borowski AG, Shrestha K, Troughton RW, Tang WHW, Thomas JD et al (2012) Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. J Am Coll Cardiol 60(20):2074–2081PubMedCrossRef Motoki H, Borowski AG, Shrestha K, Troughton RW, Tang WHW, Thomas JD et al (2012) Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure. J Am Coll Cardiol 60(20):2074–2081PubMedCrossRef
51.
Zurück zum Zitat Ng ACT, Bertini M, Borleffs CJW, Delgado V, Boersma E, Piers SRD et al (2010) Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. Am J Cardiol 106(11):1566–1573PubMedCrossRef Ng ACT, Bertini M, Borleffs CJW, Delgado V, Boersma E, Piers SRD et al (2010) Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. Am J Cardiol 106(11):1566–1573PubMedCrossRef
52.
Zurück zum Zitat Bertini M, Ng ACT, Borleffs CJW, Delgado V, Wijnmaalen AP, Nucifora G et al (2010) Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy. Am Heart J 160(4):729–736PubMedCrossRef Bertini M, Ng ACT, Borleffs CJW, Delgado V, Wijnmaalen AP, Nucifora G et al (2010) Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy. Am Heart J 160(4):729–736PubMedCrossRef
53.
Zurück zum Zitat Haugaa KH, Grenne BL, Eek CH, Ersbøll M, Valeur N, Svendsen JH et al (2013) Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC Cardiovasc Imaging 6(8):841–850PubMedCrossRef Haugaa KH, Grenne BL, Eek CH, Ersbøll M, Valeur N, Svendsen JH et al (2013) Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. JACC Cardiovasc Imaging 6(8):841–850PubMedCrossRef
Metadaten
Titel
Risk stratification for sudden cardiac death in patients with heart failure
Emerging role of imaging parameters
verfasst von
Dr. Ikram Kammoun
Emna Bennour
Lobna Laroussi
Manel Miled
Ahmed Sghaier
Karmous Rahma
Boussema Amine
Sonia Marrakchi
Salem Kachboura
Publikationsdatum
28.04.2021
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-021-05032-3

Weitere Artikel der Ausgabe 6/2021

Herz 6/2021 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.